Cutler Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,478
Closed -$20K 5302
2022
Q2
$20K Buy
+2,478
New +$23.7K ﹤0.01% 2677
2022
Q1
Sell
-600
Closed -$20K 5778
2021
Q4
$20K Sell
600
-500
-45% -$19.6K ﹤0.01% 3123
2021
Q3
$53K Buy
+1,100
New +$50.9K ﹤0.01% 2464
2021
Q1
Sell
-683
Closed -$35.6K 6065
2020
Q4
$36K Buy
+683
New +$30.9K ﹤0.01% 2236
2020
Q3
Sell
-1,741
Closed -$64.7K 5059
2020
Q2
$53K Buy
1,741
+1,200
+222% +$33.3K ﹤0.01% 1704
2020
Q1
$14K Buy
541
+300
+124% +$8.99K ﹤0.01% 2533
2019
Q4
$7K Buy
+241
New +$5.74K ﹤0.01% 2851
2017
Q4
Sell
-500
Closed -$5K 5556
2017
Q3
$5K Buy
+500
New +$4.87K ﹤0.01% 4397
2017
Q2
Sell
-13,087
Closed -$103K 6819
2017
Q1
$103K Buy
13,087
+2,900
+28% +$23.6K ﹤0.01% 1714
2016
Q4
$87K Buy
10,187
+6,387
+168% +$54.7K ﹤0.01% 2026
2016
Q3
$31K Buy
3,800
+100
+3% +$839 ﹤0.01% 2966
2016
Q2
$29K Buy
+3,700
New +$29.7K ﹤0.01% 2965

Other funds holding NEO

Cutler Group's NEO Position: Q3 2022 in Review

Cutler Group sold out of NeoGenomics (NEO) in Q3 2022, closing a stake of 2,478 shares — an estimated $20K sold.

Cutler Group first reported a position in NEO in Q2 2016 and held it in 12 quarters. The position peaked at $103K in Q1 2017. 245 funds tracked by Wall St. Rank hold NEO as of Q3 2022.

  • Cutler Group reported no remaining NeoGenomics position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 2,478 NeoGenomics shares in Q3 2022, an estimated $20K.
  • Cutler Group first reported a position in NeoGenomics in Q2 2016 and held it in 12 quarters.
  • Cutler Group's NeoGenomics position peaked at $103K in Q1 2017.
  • 245 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.